Newsroom

25.06.2018
New Canadian study to improve eradication of inhibitors in Hemophilia A patients

Toronto, Canada, June 25, 2018: – Octapharma announced today the launch of the Canadian PREVAIL (Imm...

more

18.06.2018
Octapharma announces approval of new Nuwiq® product strengths in Europe, increasing dosing flexibility for patients with haemophilia A

Lachen, Switzerland 18 June 2018: Octapharma announced today that the European Medicines Agency...

more

Career

Octapharma’s success is the result of the combined contribution of all employees, what we call “the human factor”. To embark on a challenging and rewarding career in an innovative biopharmaceutical organization, explore our global opportunities 

Career

Annual Report 2017

www.annualreport.octapharma.com